Skip to content

To compare effectiveness of two drugs-Potash Alum and Sucralfate in the treatment of Recurrent Aphthous Ulcers: a clinical trial

Comparative evaluation of Potash alum and Sucralfate in the management of Recurrent Aphthous ulcers (RAU): a double-blind randomized trial - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088745
Enrollment
80
Registered
2025-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K137- Other and unspecified lesions of oral mucosa Health Condition 2: K137- Other and unspecified lesions of oral mucosa Health Condition 3: R198- Other specified symptoms and signsinvolving the digestive system and abdomen Health Condition 4: K120- Recurrent oral aphthae

Interventions

Intervention1: Potash Alum: 30 gms of pure potash alum powder will be dispensed to the patient in a container along with a small spoon of measure approximately equal to 0.5gms of alum. Patient will be

Sponsors

Dr Diksha Aggarwal
Lead Sponsor
Dr Harvansh Singh Judge Institute of Dental Sciences and Hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with a history of RAU 2. Presence of 1-3 ulcers with duration less than or equal to 48 hours

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating females. 2. Presence of secondary ulcers (trauma, infections or systemic disorders) 3. History of taking antibiotics/corticosteroids/anticonvulsants in the preceding one week 4. Periodontal disease (Grade 3 or above as per PSR (Periodontal Screening and recording) Index)

Design outcomes

Primary

MeasureTime frame
Compare efficacy of potash alum and sucralfate in management of recurrent aphthous ulcers with respect to effect on: Healing time Pain relief Salivary count of Prevotella sp. and E.coli Salivary markers(Nitric oxide, pH, IgA)Timepoint: Day 3 Day 7/healing of ulcer

Secondary

MeasureTime frame
1. To monitor and record any adverse effects or patient-reported discomfort during the treatment period 2. To record any recurrence in a 30 day period Timepoint: Day 3 Day 7/healing of ulcer Day 30

Countries

India

Contacts

Public ContactDr Anubha Gulati

Dr. Harvansh Singh Judge Institute of Dental Sciences and Hospital, sector 25, Panjab University

shallygupta72@yahoo.in9914016745

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026